Published in Eur J Med Res on June 28, 2010
Maraviroc: a review of its use in HIV infection and beyond. Drug Des Devel Ther (2015) 1.29
Analysis of physicochemical and structural properties determining HIV-1 coreceptor usage. PLoS Comput Biol (2013) 0.85
Prediction of HIV-1 coreceptor usage (tropism) by sequence analysis using a genotypic approach. J Vis Exp (2011) 0.84
An expanded model of HIV cell entry phenotype based on multi-parameter single-cell data. Retrovirology (2012) 0.82
Molecular epidemiology of HIV in two highly endemic areas of northeastern South Africa. Arch Virol (2011) 0.78
Virological and immunological response to antiretroviral regimens containing maraviroc in HIV type 1-infected patients in clinical practice: role of different tropism testing results and of concomitant treatments. AIDS Res Hum Retroviruses (2013) 0.77
Parameters Influencing Baseline HIV-1 Genotypic Tropism Testing Related to Clinical Outcome in Patients on Maraviroc. PLoS One (2015) 0.76
Durability and Effectiveness of Maraviroc-Containing Regimens in HIV-1-Infected Individuals with Virological Failure in Routine Clinical Practice. PLoS One (2015) 0.75
Antiretroviral treatment of adult HIV infection: 2008 recommendations of the International AIDS Society-USA panel. JAMA (2008) 11.72
Raltegravir with optimized background therapy for resistant HIV-1 infection. N Engl J Med (2008) 7.33
Maraviroc for previously treated patients with R5 HIV-1 infection. N Engl J Med (2008) 7.31
Development and characterization of a novel single-cycle recombinant-virus assay to determine human immunodeficiency virus type 1 coreceptor tropism. Antimicrob Agents Chemother (2006) 4.14
Subgroup analyses of maraviroc in previously treated R5 HIV-1 infection. N Engl J Med (2008) 3.71
Bioinformatics prediction of HIV coreceptor usage. Nat Biotechnol (2007) 3.64
A double-blind, placebo-controlled trial of maraviroc in treatment-experienced patients infected with non-R5 HIV-1. J Infect Dis (2009) 1.79
Design and validation of new genotypic tools for easy and reliable estimation of HIV tropism before using CCR5 antagonists. J Antimicrob Chemother (2009) 1.43
Prevalence of X4 tropic viruses in patients recently infected with HIV-1 and lack of association with transmission of drug resistance. J Antimicrob Chemother (2007) 1.28
HIV tropism: diagnostic tools and implications for disease progression and treatment with entry inhibitors. AIDS (2006) 1.23
Genotypic susceptibility scores and HIV type 1 RNA responses in treatment-experienced subjects with HIV type 1 infection. AIDS Res Hum Retroviruses (2008) 1.15
Persistence of drug-resistant HIV-1 after a structured treatment interruption and its impact on treatment response. AIDS (2003) 1.10
Phenotypic assays for the determination of coreceptor tropism in HIV-1 infected individuals. Eur J Med Res (2007) 0.99
Maraviroc: integration of a new antiretroviral drug class into clinical practice. J Antimicrob Chemother (2008) 0.95
Evolution of HIV resistance during treatment interruption in experienced patients and after restarting a new therapy. J Clin Virol (2005) 0.88
A new class of anti-HIV therapy and new challenges. N Engl J Med (2008) 0.83
Prediction of Virologic Outcome of Salvage Antiretroviral Treatment by Different Systems for Interpreting Genotypic HIV Drug Resistance. J Int Assoc Physicians AIDS Care (Chic) (2007) 0.80
DNA diagnostics--molecular techniques and automation. Science (1988) 8.85
A ligase-mediated gene detection technique. Science (1988) 7.61
Evaluation of methods to identify the Klebsiella pneumoniae carbapenemase in Enterobacteriaceae. J Clin Microbiol (2007) 7.30
Public-health impact of outdoor and traffic-related air pollution: a European assessment. Lancet (2000) 6.95
Identification of a point mutation in the voltage-gated sodium channel gene of Kenyan Anopheles gambiae associated with resistance to DDT and pyrethroids. Insect Mol Biol (2000) 5.81
DNA gyrase gyrA mutations in ciprofloxacin-resistant strains of Staphylococcus aureus: close similarity with quinolone resistance mutations in Escherichia coli. J Bacteriol (1990) 5.13
Functional significance of cell volume regulatory mechanisms. Physiol Rev (1998) 4.59
Long-term survival in patients with hereditary hemochromatosis. Gastroenterology (1996) 4.00
Long-term follow-up of HBeAg-positive patients treated with interferon alfa for chronic hepatitis B. N Engl J Med (1996) 3.41
Prognosis of chronic hepatitis C: results of a large, prospective cohort study. Hepatology (1998) 3.00
Regular physical exercise corrects endothelial dysfunction and improves exercise capacity in patients with chronic heart failure. Circulation (1998) 2.90
Automated DNA diagnostics using an ELISA-based oligonucleotide ligation assay. Proc Natl Acad Sci U S A (1990) 2.88
European guidelines on the clinical management of HIV-1 tropism testing. Lancet Infect Dis (2011) 2.47
Identification of a novel class of insect glutathione S-transferases involved in resistance to DDT in the malaria vector Anopheles gambiae. Biochem J (2001) 2.35
Yeast mutants auxotrophic for choline or ethanolamine. J Bacteriol (1980) 2.24
Lyme borreliosis: clinical case definitions for diagnosis and management in Europe. Clin Microbiol Infect (2011) 2.23
Assessment of deaths attributable to air pollution: should we use risk estimates based on time series or on cohort studies? Am J Epidemiol (2001) 2.19
Prior cytomegalovirus infection and the risk of restenosis after percutaneous transluminal coronary balloon angioplasty. Circulation (1999) 2.13
Preclinical evaluation of HBY 097, a new nonnucleoside reverse transcriptase inhibitor of human immunodeficiency virus type 1 replication. Antimicrob Agents Chemother (1995) 2.04
[Demonstration of HFE polymorphism in German patients with hereditary hemochromatosis]. Dtsch Med Wochenschr (1999) 2.03
Development and clinical significance of the musculus dorsoepitrochlearis in men. Clin Anat (2009) 1.98
T- and B-cell responses to different hepatitis C virus antigens in patients with chronic hepatitis C infection and in healthy anti-hepatitis C virus--positive blood donors without viremia. Hepatology (1996) 1.88
Regulation of the multidrug resistance protein 2 in the rat liver by lipopolysaccharide and dexamethasone. Gastroenterology (1999) 1.87
Epidemic intelligence: a new framework for strengthening disease surveillance in Europe. Euro Surveill (2006) 1.75
Proton magnetic resonance spectroscopy of the brain in symptomatic and asymptomatic patients with liver cirrhosis. Gastroenterology (1997) 1.70
Evidence for a vasoconstriction-mediating receptor for UTP, distinct from the P2 purinoceptor, in rabbit ear artery. Naunyn Schmiedebergs Arch Pharmacol (1987) 1.68
Increased frequency of the HLA-DR15 (B1*15011) allele in German patients with self-limited hepatitis C virus infection. Eur J Clin Invest (1999) 1.68
Expression of the peripheral-type benzodiazepine receptor and apoptosis induction in hepatic stellate cells. Gastroenterology (2001) 1.66
Mitochondrial aldehyde dehydrogenase from human liver. Primary structure, differences in relation to the cytosolic enzyme, and functional correlations. Eur J Biochem (1985) 1.65
Hepatorenal reflex regulating kidney function. Hepatology (1991) 1.61
Intake of marine fat, rich in (n-3)-polyunsaturated fatty acids, may increase birthweight by prolonging gestation. Lancet (1986) 1.60
Genetic mapping of two loci affecting DDT resistance in the malaria vector Anopheles gambiae. Insect Mol Biol (2000) 1.57
Identification of clusters of biallelic polymorphic sequence-tagged sites (pSTSs) that generate highly informative and automatable markers for genetic linkage mapping. Genomics (1992) 1.55
Patient Profile: Inuvik General Hospital and Four Regional Nursing Stations, NWT. Can Fam Physician (1980) 1.53
Collaboration, cholera, and cyclones: a project to improve point-of-use water quality in Madagascar. Am J Public Health (2001) 1.52
Multicenter clinical trial of recombinant human insulin-like growth factor I in patients with acute renal failure. Kidney Int (1999) 1.51
Plasmodium knowlesi infection imported to Germany, January 2013. Euro Surveill (2013) 1.50
Cortical origin of mini-asterixis in hepatic encephalopathy. Neurology (2002) 1.50
Release of chemosterilized males for the control of Anopheles albimanus in El Salvador. 3. Field methods and population control. Am J Trop Med Hyg (1974) 1.48
Genetic mapping of genes conferring permethrin resistance in the malaria vector, Anopheles gambiae. Insect Mol Biol (2004) 1.48
LPS and TNFalpha induce SOCS3 mRNA and inhibit IL-6-induced activation of STAT3 in macrophages. FEBS Lett (1999) 1.46
Anal endosonography and manometry: comparison in patients with defecation problems. Dis Colon Rectum (1997) 1.46
Parvovirus B19 DNA is frequently present in recombinant coagulation factor VIII products. Thromb Haemost (1996) 1.46
Hepatocyte heterogeneity in glutamine and ammonia metabolism and the role of an intercellular glutamine cycle during ureogenesis in perfused rat liver. Eur J Biochem (1983) 1.43
Cardiotoxicity of the antiproliferative compound fluorouracil. Drugs (1999) 1.42
Roles of DnaK and RpoS in starvation-induced thermotolerance of Escherichia coli. J Bacteriol (1998) 1.42
Actions of extracellular UTP and ATP in perfused rat liver. A comparative study. Eur J Biochem (1987) 1.40
Serological and virological markers of human parvovirus B19 infection in sera of hemophiliacs. Thromb Haemost (1994) 1.40
The effects of a physical training program on patients with osteoarthritis of the knees. Arch Phys Med Rehabil (1998) 1.40
Emergence of ciprofloxacin resistance in nosocomial methicillin-resistant Staphylococcus aureus isolates. Resistance during ciprofloxacin plus rifampin therapy for methicillin-resistant S aureus colonization. Arch Intern Med (1990) 1.39
Gestational age in relation to marine n-3 fatty acids in maternal erythrocytes: a study of women in the Faroe Islands and Denmark. Am J Obstet Gynecol (1991) 1.39
[Influencing of mitosis rate in endometrial carcinomas using 17-hydroxynorprogesterone capronate in women]. Arch Gynakol (1972) 1.38
Benzimidazoles in the treatment of alveolar echinococcosis: a comparative study and review of the literature. J Antimicrob Chemother (2000) 1.35
Water, K+, H+, lactate and glucose fluxes during cell volume regulation in perfused rat liver. Pflugers Arch (1989) 1.31
Characterization and natural course of cardiac autonomic nervous dysfunction in HIV-infected patients. AIDS (1997) 1.29
Response to interferon alfa is hepatitis B virus genotype dependent: genotype A is more sensitive to interferon than genotype D. Gut (2005) 1.28
Prediction of response to antiretroviral therapy by human experts and by the EuResist data-driven expert system (the EVE study). HIV Med (2010) 1.24
Functional hepatocyte heterogeneity in ammonia metabolism. The intercellular glutamine cycle. J Hepatol (1985) 1.22
Mutations of the core promoter and response to interferon treatment in chronic replicative hepatitis B. Hepatology (2000) 1.22
Erythrocyte levels compared with reported dietary intake of marine n-3 fatty acids in pregnant women. Br J Nutr (1995) 1.22
Activation of pyruvate dehydrogenase during metabolism of ammonium ions in hemoglobin-free perfused rat liver. Eur J Biochem (1975) 1.21
Identification of the phosphorylation site for cAMP-dependent protein kinase on Na+,K(+)-ATPase and effects of site-directed mutagenesis. J Biol Chem (1994) 1.21
Gestation length and birth weight in relation to intake of marine n-3 fatty acids. Br J Nutr (1995) 1.21
Decreased frequency of HCV core-specific peripheral blood mononuclear cells with type 1 cytokine secretion in chronic hepatitis C. J Hepatol (1999) 1.20
Increased incidence of cancer in adult Gaucher disease in Western Europe. Blood Cells Mol Dis (2005) 1.19
Comparison of three classes of human liver alcohol dehydrogenase. Emphasis on different substrate binding pockets. Eur J Biochem (1990) 1.19
Association of cyclophosphamide pharmacokinetics to polymorphic cytochrome P450 2C19. Pharmacogenomics J (2005) 1.19
CYP2D6 polymorphism and clinical effect of the antidepressant venlafaxine. J Clin Pharm Ther (2006) 1.16
A phase II double-blind study to investigate efficacy and safety of two doses of the triple angiokinase inhibitor BIBF 1120 in patients with relapsed advanced non-small-cell lung cancer. Ann Oncol (2011) 1.15
Purification, characterization and HPLC assay of Salmonella glucose-1-phosphate thymidylyl-transferase from the cloned rfbA gene. Eur J Biochem (1993) 1.14
Synthetic cascades are enabled by combining biocatalysts with artificial metalloenzymes. Nat Chem (2012) 1.14
The measurement of abnormal movement: methods developed for Huntington's disease. Neurobehav Toxicol Teratol (1984) 1.14
Regulation of flux through glutaminase and glutamine synthetase in isolated perfused rat liver. Biochim Biophys Acta (1983) 1.13
Biweekly cetuximab and irinotecan as third-line therapy in patients with advanced colorectal cancer after failure to irinotecan, oxaliplatin and 5-fluorouracil. Ann Oncol (2008) 1.13
Activation of the Janus kinase/signal transducer and activator of transcription pathway by osmotic shock. J Biol Chem (1998) 1.11
Ligand requirements of the human corticotropin-releasing factor-binding protein. Endocrinology (1995) 1.11
Regulation of liver cell volume and proteolysis by glucagon and insulin. Biochem J (1991) 1.10
Liver cell volume and protein synthesis. Biochem J (1992) 1.10
Genotypic coreceptor analysis. Eur J Med Res (2007) 1.10
Blood donors in Kenya: a comparison of voluntary and family replacement donors based on a population-based survey. Vox Sang (2010) 1.10
Color Doppler sonographic evaluation of spontaneous portosystemic shunts and inversion of portal venous flow in patients with cirrhosis. J Clin Ultrasound (2000) 1.10
Essential function of linoleic acid esterified in acylglucosylceramide and acylceramide in maintaining the epidermal water permeability barrier. Evidence from feeding studies with oleate, linoleate, arachidonate, columbinate and alpha-linolenate. Biochim Biophys Acta (1985) 1.10
Intermittent intrahepatic cholestasis of unknown etiology in five young males from the Faroe Islands. Acta Med Scand (1969) 1.10
Hepatocyte swelling leads to rapid decrease of the G-/total actin ratio and increases actin mRNA levels. FEBS Lett (1992) 1.09
Serum amino acid concentrations in nine athletes before and after the 1993 Colmar ultra triathlon. Int J Sports Med (1995) 1.09
Control of hepatic proteolysis by amino acids. The role of cell volume. Eur J Biochem (1991) 1.08
The role of health care in the spread of HIV/AIDS in Africa: evidence from Kenya. Int J STD AIDS (2009) 1.08
CD30 induction and cytokine profiles in hepatitis C virus core-specific peripheral blood T lymphocytes. J Immunol (1997) 1.08
Cell hydration controls autophagosome formation in rat liver in a microtubule-dependent way downstream from p38MAPK activation. Biochem J (2001) 1.07
Inhibition of proteolysis by cell swelling in the liver requires intact microtubular structures. Biochem J (1995) 1.07
Regulation of cell volume in the perfused rat liver by hormones. Biochem J (1991) 1.07
HLA-DQ6 and ingestion of contaminated water: possible gene-environment interaction in an outbreak of Leptospirosis. Genes Immun (2004) 1.07
Activation of extracellular signal-regulated kinases Erk-1 and Erk-2 by cell swelling in H4IIE hepatoma cells. Biochem J (1995) 1.06
Preliminary results on the action of cosmic heavy ions on the development of eggs of Artemia salina. Life Sci Space Res (1974) 1.05
Ion transport in hepatocytes: mechanisms and correlations to cell volume, hormone actions and metabolism. J Hepatol (1996) 1.04
Heat-related mortality in selected United States cities, summer 1999. Am J Forensic Med Pathol (2001) 1.04
Modification of liver cell volume by insulin and glucagon. Pflugers Arch (1991) 1.04
Association between duplex Doppler sonographic flow pattern in right hepatic vein and various liver diseases. J Clin Ultrasound (2001) 1.03
Cell volume regulatory responses of isolated perfused rat liver. The effect of amino acids. Biol Chem Hoppe Seyler (1990) 1.03